Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Nat Ecol Evol. 2020 Sep;4(9):1268-1278. doi: 10.1038/s41559-020-1235-1. Epub 2020 Jul 6.
In the absence of antibiotics, it is essential that antibiotic resistance has a fitness cost for microorganisms if suspending antibiotics treatment is to be a useful strategy for reducing antibiotic resistance. However, the cost of antibiotic resistance within the complex ecosystem of the mammalian gut is not well understood. Here, using mice, we show that the same antibiotic resistance mutation can reduce fitness in one host, while being neutral or even increasing fitness in other hosts. Such antagonistic pleiotropy is shaped by the microbiota because resistance in germ-free mice is consistently costly across all hosts, and the host-specific effect on antibiotic resistance is reduced in hosts with similar microbiotas. Using an eco-evolutionary model of competition for resources, we identify a general mechanism that underlies between-host variation and predicts that the dynamics of compensatory evolution of resistant bacteria should be host specific, a prediction that was supported by experimental evolution in vivo. The microbiome of each human is close to unique, and our results suggest that the short-term cost of resistances and their long-term within-host evolution are also highly personalized, a finding that may contribute to the observed variable outcome of withdrawing antibiotics to reduce resistance levels.
如果要暂停抗生素治疗成为减少抗生素耐药性的一种有效策略,那么在没有抗生素的情况下,抗生素耐药性对微生物产生适应性代价是至关重要的。然而,哺乳动物肠道这一复杂生态系统中抗生素耐药性的代价还没有被很好地理解。在这里,我们使用小鼠表明,相同的抗生素耐药性突变在一个宿主中可能会降低适应性,而在其他宿主中则是中性的,甚至会增加适应性。这种拮抗多效性是由微生物群塑造的,因为在无菌小鼠中,所有宿主的耐药性都是持续存在代价的,而在具有相似微生物群的宿主中,对抗生素耐药性的宿主特异性影响会降低。我们使用资源竞争的生态进化模型,确定了一个普遍的机制,该机制是宿主间变异的基础,并预测耐药菌的补偿性进化动态应该是宿主特异性的,这一预测得到了体内实验进化的支持。每个人的微生物组都接近独一无二,我们的结果表明,耐药性的短期成本及其在宿主内的长期进化也具有高度的个体性,这一发现可能有助于解释在停止使用抗生素以降低耐药性水平时观察到的不同结果。